Drug Pricing - MM+M - Medical Marketing and Media

Drug Pricing

All articles by Drug Pricing

Telehealth, drug prices, vaccine rollout headline day 2 of JPMorgan Healthcare Conference
Telehealth, drug prices, vaccine rollout headline day 2 of JPMorgan Healthcare Conference
Lecia Bushak
January 12, 2021
5:22 pm

Execs from Pfizer, Sanofi and CVS Health shared company updates with the virtual throng.

Health Policy 2021: COVID-19 pandemic, drug pricing, ACA reform and data privacy
Health Policy 2021: COVID-19 pandemic, drug pricing, ACA reform and data privacy
Larry Dobrow
December 1, 2020
9:45 am

Ending the pandemic is clearly the top public-health priority for the incoming Biden administration. Will action on drug pricing, ACA reform and data privacy follow?

Five things for pharma marketers to know: Wednesday, September 30, 2020
Five things for pharma marketers to know: Wednesday, September 30, 2020
Ray Pelosi
September 30, 2020
5:00 am

California to attempt to develop generic drugs; Recovered COVID-19 patients in South Korea experienced side effects; Children make up 10% of coronavirus cases in the U.S.

COVID-19 kicks drug pricing down the road
COVID-19 kicks drug pricing down the road
Alison Kanski
September 9, 2020
5:00 am

The attention to the upcoming presidential election also dims the likelihood of legislation efforts until 2021.

Pharma industry, Trump publicly negotiate drug pricing rules
Pharma industry, Trump publicly negotiate drug pricing rules
Alison Kanski
September 2, 2020
5:00 am

President Trump is putting pressure on the pharma industry ahead of the presidential election.

Five things for pharma marketers to know: Wednesday, August 26, 2020
Five things for pharma marketers to know: Wednesday, August 26, 2020
Alison Kanski
August 26, 2020
5:00 am

Nursing home guidelines require testing for staff, residents; Justice Department to charge Teva in price-fixing probe; Verily launches subsidiary focused on stop-loss health insurance.

Pandemic or no, pharma needs to push drug pricing dialogue
Pandemic or no, pharma needs to push drug pricing dialogue
Alison Kanski
August 5, 2020
5:00 am

Although the world is still months away from a COVID-19 vaccine, it’s imperative that pharma companies have the conversation right now about the cost of innoculation.

Five things for pharma marketers to know: Wednesday, August 5, 2020
Five things for pharma marketers to know: Wednesday, August 5, 2020
Alison Kanski
August 5, 2020
5:00 am

Attorneys general calls on government to lower price of remdesivir; FDA finalizing CBD guidelines; Apple and UCLA begin depression and anxiety study.

Five things for pharma marketers to know: Wednesday, July 29, 2020
Five things for pharma marketers to know: Wednesday, July 29, 2020
Alison Kanski
July 29, 2020
5:00 am

Advocates call on Facebook to control vaccine misinformation; Democratic lawmakers to investigate government’s role in developing remdesivir; Pfizer CEO criticizes Trump drug price orders.

Five things for pharma marketers to know: Monday, July 27, 2020
Five things for pharma marketers to know: Monday, July 27, 2020
Alison Kanski
July 27, 2020
5:00 am

Opioid labels must include information about naloxone; Three of four Americans support mask requirements; Submit a cover design for the MM&M Hall of Femme issue.

  • Culture drives the company

    Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.

  • From Our Partners